|
Video: What is a Stock Split?
|
|
BeyondSpring is a holding company. Through its subsidiaries, Co. is principally engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. Co.'s primary asset, Plinabulinv, a Selective Immunomodulating Microtubule-Binding Agent, is being developed as a pipeline in a drug in various cancer indications. Co. is also developing three small molecule immune agents in preclinical stages. In addition, Co.'s subsidiary, SEED Therapeutics Inc., is utilizing a certain Targeted Protein Degradation platform, or molecular glue technology, to develop therapeutic agents from internal research and development efforts and from collaboration. According to our BeyondSpring stock split history records, BeyondSpring has had 0 splits. | |
|
BeyondSpring (BYSI) has 0 splits in our BeyondSpring stock split history database.
Looking at the BeyondSpring stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into BeyondSpring shares, starting with a $10,000 purchase of BYSI, presented on a split-history-adjusted basis factoring in the complete BeyondSpring stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/10/2017 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$19.25 |
|
End price/share: |
$3.57 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-81.45% |
|
Average Annual Total Return: |
-21.25% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,855.04 |
|
Years: |
7.05 |
|
|
|
|
|